Executives from Puig and Estée Lauder shaking hands amid $40B merger talks, with stock charts showing price swings and luxury beauty products on display.
Executives from Puig and Estée Lauder shaking hands amid $40B merger talks, with stock charts showing price swings and luxury beauty products on display.
Image generated by AI

Puig and Estée Lauder in talks for potential $40 billion merger

Image generated by AI

Puig and The Estée Lauder Companies disclosed after Monday's market close that they are discussing a possible business combination, with no agreement reached. Puig notified Spain's CNMV on March 23, 2026. The deal could create a $40 billion beauty group with $20 billion in combined sales, prompting Estée Lauder shares to drop 7.7% while Puig's rose 11%.

Spanish beauty conglomerate Puig notified Spain's National Securities Market Commission (CNMV) on March 23, 2026, that it is holding talks with New York-based The Estée Lauder Companies (ELC) on a potential merger. 'Puig confirms it is holding conversations on a possible business combination with The Estée Lauder, which would imply a potential merger of both businesses. No definitive decision has been taken nor any agreement reached,' the filing stated. Unless a firm agreement is secured, no assurances can be given on the deal or terms.

Financial Times and Wall Street Journal reports indicate the combined entity could be valued at $40 billion, with over €15 billion in sales via a cash-and-ELC shares structure. Fiscal 2025 projections show combined sales of $20 billion: ELC at $14.3 billion (down 8%) and Puig at €5 billion (up 7.8%). Markets reacted sharply after hours, with ELC shares falling 7.7% and Puig's rising 11%.

Puig, listed in 2024 at €24.50 per share, owns brands including Carolina Herrera, Jean Paul Gaultier, Rabanne, Dries Van Noten, Charlotte Tilbury, Dr. Barbara Sturm, and Byredo. ELC's portfolio features La Mer, MAC Cosmetics, Bobbi Brown, The Ordinary, Le Labo, and Tom Ford beauty. Both companies excel in fragrances and skincare, with growth potential in markets like India.

Recent leadership changes include Puig appointing José Manuel Albesa as CEO on March 17 (replacing Marc Puig, now executive chairman) and Miquel Àngel Serra as CFO. At ELC, Stéphane de La Faverie took over as CEO in January 2025 to lead a turnaround amid challenges in China and travel retail, including 2025 losses and restructuring. ELC reported 4% organic net sales growth to $4.16 billion in Q2 fiscal 2026 (ended December 31, 2025), with de La Faverie noting 'excellent second-quarter results' and progress on 'Beauty Reimagined.'

Analysts see merger potential to challenge L'Oréal, Unilever, and Shiseido. Ilya Seglin of Cascadia Capital cited cultural alignment from family ownership, while Neil Saunders of GlobalData said it provides ELC a 'growth story' despite ongoing revitalization needs.

What people are saying

Discussions on X highlight excitement about the potential $40 billion beauty conglomerate from Puig and Estée Lauder merger talks, emphasizing synergies in fragrances, skincare, and luxury brands. Investors note EL shares dropping 7-8% due to dilution fears while PUIG rises on takeover premium speculation. Skeptics question if it's a true merger or EL acquisition, citing valuation mismatches and integration risks. Analysts see strategic fit but caution no deal is guaranteed.

Related Articles

Jose Manuel Albesa shakes hands with Marc Puig in a boardroom, symbolizing Puig's CEO transition to align strategy and M&A.
Image generated by AI

Puig names Jose Manuel Albesa as new CEO

Reported by AI Image generated by AI

Puig has appointed Jose Manuel Albesa as chief executive officer, effective immediately. He succeeds Marc Puig, who moves to executive chairman. The change aims to align the company's strategic vision and M&A efforts.

Dr. Barbara Sturm, founder of the eponymous skincare brand, sold her company to Puig in January 2024 and now serves as chief product development officer and brand ambassador. The acquisition has enabled expanded research and development, focusing on innovation in anti-inflammatory and regenerative skincare. Sturm retains a minority stake while emphasizing the brand's scientific foundation.

Reported by AI

Japanese cosmetics giant Shiseido is grappling with its biggest challenge in decades, stemming from a costly misfire in North America and eroding market share to nimble Asian rivals. Six years ago, the company spent $845 million acquiring the American brand Drunk Elephant to tap into younger customers, but has since written off more than half the investment due to falling profits and sales.

BBVA's hostile takeover bid (OPA) to absorb Banco Sabadell has failed after 17 months, securing only about 25% acceptance of the capital, below the 30% minimum threshold set. This marks the second failure for BBVA president Carlos Torres, following an unsuccessful attempt in 2020. Rejection from shareholders, regulators, and the Spanish government has shaped the outcome of this banking battle.

Reported by AI

Talgo's shareholders have approved the financial restructuring allowing the Basque Government, Sidenor, and SEPI to take control of the company. The deal involves Trilantic's exit and entry of new Basque and state investors. The process aims to stabilize the firm after two years of uncertainty.

A Seeking Alpha analyst has reaffirmed a buy rating on Alcon (ALC) stock, highlighting its eyecare portfolio amid the abandoned acquisition of STAAR Surgical. The assessment points to resilience against market shocks and positive earnings forecasts for FY26.

Reported by AI

An analyst at Seeking Alpha has rated Unilever (NYSE:UL) stock as a hold, citing structural challenges following its ice cream spin-off. The rating comes with a fair value target of £40 per share. The assessment highlights slowed growth and valuation concerns for 2026.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline